The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...
The 2026 PSMA & Beyond conference featured a clinical development session and presentation by Dr. Alicia Morgans discussing the incorporation of PSMA PETs in registrational trials. To do this, Dr.
Morning Overview on MSN
New prostate cancer cell atlas may aid earlier detection, researchers say
A team of researchers has constructed the most detailed single-cell map of the adult human prostate to date, cataloging more ...
The 2026 PSMA & Beyond conference featured a targeting the cell surface session and presentation by Dr. Rahul Aggarwal discussing DLL3 and whether target expression determines the method of targeting.
Men with an intellectual disability face significant inequalities throughout the entire prostate cancer care pathway, study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results